Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Fennec Pharmaceuticals Inc (FRX.TO)

Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference GlobeNewswire - Wed Nov 13, 5:27AM CST

FRX.TO : 5.65 (-7.38%)
FENC : 3.99 (-9.32%)
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Thu Nov 7, 5:13AM CST

FRX.TO : 5.65 (-7.38%)
FENC : 3.99 (-9.32%)
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 GlobeNewswire - Thu Oct 31, 5:23AM CDT

FRX.TO : 5.65 (-7.38%)
FENC : 3.99 (-9.32%)
Stocks in play: Fennec Pharmaceuticals Inc. Baystreet - Mon Oct 28, 8:45AM CDT

Announced that it has strengthened its executive leadership team with the appointments of Pierre S. ...

FRX.TO : 5.65 (-7.38%)
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth GlobeNewswire - Mon Oct 28, 5:23AM CDT

FRX.TO : 5.65 (-7.38%)
FENC : 3.99 (-9.32%)
Stocks in play: Fennec Pharmaceuticals Inc. Baystreet - Thu Mar 21, 8:43AM CDT

Reported its financial results for the fiscal year ended December 31, 2023. Net losses for the fourth ...

FRX.TO : 5.65 (-7.38%)
Stocks in play: Fennec Pharmaceuticals Inc. Baystreet - Tue Mar 19, 8:38AM CDT

Will release its full-year and fourth-quarter 2023 financial results before the opening of the U.S. ...

FRX.TO : 5.65 (-7.38%)
Stocks in play: Fennec Pharmaceuticals Inc. Baystreet - Mon May 8, 2023

Will release its first-quarter 2023 financial results before the opening of the U.S. financial markets ...

FRX.TO : 5.65 (-7.38%)
Stocks in play: Fennec Pharmaceuticals Inc. Baystreet - Thu Mar 30, 2023

Today reported its financial results for the fiscal year ended December 31, 2022. Net losses for the ...

FRX.TO : 5.65 (-7.38%)
Stocks in play: Fennec Pharmaceuticals Inc Baystreet - Tue Jan 31, 2023

Announced that the U.S. Food and Drug Administration has granted Orphan Drug Exclusivity to PEDMARK® ...

FRX.TO : 5.65 (-7.38%)

Barchart Exclusives

3 Oversold Dividend Aristocrats Ready To Explode in 2025 Barchart - Fri Nov 15, 6:00PM CST
These three companies all have one thing in common: they are all on sale. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot